Journal of Nuclear Medicine: 64 (5)

May 1, 2023; Volume 64,Issue 5

Cover image

FEATURED ARTICLE

Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities. Nader Hirmas et al. See page 711.

In this issue

Issue highlights

Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities
Fibroblast Activation Protein–Targeted Radioligand Therapy for Treatment of Solid Tumors

Performance Evaluation of the uEXPLORER Total-Body PET/CT Scanner Based on NEMA NU 2-2018 with Additional Tests to Characterize PET Scanners with a Long Axial Field of View
Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients
Impact of ⁶⁸Ga-FAPI PET/CT Imaging on the Therapeutic Management of Primary and Recurrent Pancreatic Ductal Adenocarcinomas
Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns
Molecular Imaging Findings on Acute and Long-Term Effects of COVID-19 on the Brain: A Systematic Review

More...

Main menu

User menu

Search

Table of Contents

Cover image

In this issue

Issue highlights

Jump to